Virios Therapeutics Announces Initial FDA Feedback On Proposed IMC-1 Phase 3 Program For Treatment o
- RARA KOKO GOOD VIBES MAN
- May 3, 2023
- 1 min read
Virios Therapeutics Announces Initial FDA Feedback On Proposed IMC-1 Phase 3 Program For Treatment of Fibromyalgia; Says Final Toxicology Results To Be Submitted To FDA In

May 2023
Comentários